May 5, 2026
1 min read

BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback

The German vaccine maker plans to wind down operations at a handful of its sites in Germany plus one in Singapore, putting as many as 1,860 jobs on the chopping block.

Leave a Reply

Your email address will not be published.

Previous Story

‘I’m a midlife hormone doctor – these are the longevity habits that actually work after 50’

Next Story

Novartis to close German manufacturing site, cutting 220 jobs

Previous Story

‘I’m a midlife hormone doctor – these are the longevity habits that actually work after 50’

Next Story

Novartis to close German manufacturing site, cutting 220 jobs

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader

STAT+: A new attack on AMA’s billing codes

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Brain
Go toTop